CEP 1612: proteasome inhibitor
ID Source | ID |
---|---|
PubMed CID | 9939783 |
MeSH ID | M0302629 |
Synonym |
---|
cep1612 |
cep-1612 |
phthalimide-(ch2)8ch(cyclopentyl)co-nitroarginyl-leucinal |
189036-01-9 |
cep 1612 |
unii-9k6u075027 |
phthalimide-(ch2)8ch(cyclopentyl)co-arg(no2)-leu-h |
9k6u075027 , |
2h-isoindole-2-decanamide, alpha-cyclopentyl-n-(1-(((1-formyl-3-methylbutyl)amino)carbonyl)-4-((imino(nitroamino)methyl)amino)butyl)-1,3-dihydro-1,3-dioxo-, (n(s(s)))-(partial)- |
2h-isoindole-2-decanamide, alpha-cyclopentyl-n-((1s)-1-((((1s)-1-formyl-3-methylbutyl)amino)carbonyl)-4-((imino(nitroamino)methyl)amino)butyl)-1,3-dihydro-1,3-dioxo- |
2h-isoindole-2-decanamide, .alpha.-cyclopentyl-n-((1s)-1-((((1s)-1-formyl-3-methylbutyl)amino)carbonyl)-4-((imino(nitroamino)methyl)amino)butyl)-1,3-dihydro-1,3-dioxo- |
2h-isoindole-2-decanamide, .alpha.-cyclopentyl-n-(1-(((1-formyl-3-methylbutyl)amino)carbonyl)-4-((imino(nitroamino)methyl)amino)butyl)-1,3-dihydro-1,3-dioxo-, (n(s(s)))-(partial)- |
Q27272662 |
n-[(2s)-5-[[amino(nitramido)methylidene]amino]-1-[[(2s)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]-2-cyclopentyl-10-(1,3-dioxoisoindol-2-yl)decanamide |
AKOS040751074 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.76) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |